Newsmeme!
Discover News you didn't know existed
Hologic, Inc. (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the results of the Cervista HPV high-risk pivotal clinical trial. The Cervista HPV high-risk test is currently under review by the FDA in the U.S.
No tags found at this time. Be the first to tag this news item, learn more.
Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials - Earthtimes
Author : Hologic, Inc. BEDFORD, Mass. , Nov. 13 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the ...
PRESS RELEASE: Hologic Releases the Results of the Cervista(TM) HPV ... - Beurs.nl
PRESS RELEASE: Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials Vrijdag 14 November 2008 06:22 Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials BEDFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Hologic, Inc ...
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |